Case Report
Copyright ©The Author(s) 2022.
World J Clin Cases. May 26, 2022; 10(15): 4985-4990
Published online May 26, 2022. doi: 10.12998/wjcc.v10.i15.4985
Figure 1
Figure 1 Radionuclide bone imaging indicated progression on bone. A: Before the treatment; B: Three months later.
Figure 2
Figure 2 Prostate-specific membrane antigen positron emission tomography – computed tomography examination showed abnormal prostate-specific membrane antigen aggregation was significantly reduced, and bone metastasis was significantly improved compared with baseline. A, B: Before the treatment; C, D: Three months later.
Figure 3
Figure 3 Prostate-specific antigen curve.